IL-17 inhibitors may help patients with CARD9 mutations: Early study
October 16, 2023
Research led by Ruth Napier, Ph.D., indicates patients with the autoimmune condition ankylosing spondylitis who have a particular mutation in the CARD9 gene may respond well to biologic treatments that inhibit the protein IL-17.